New Frontiers of Fecal Microbiota Transplantation
New research presented this weekend at AGA’s 2014 James W. Freston Conference in Chicago, IL, highlights significant advances in this field, and confirms the promise of FMT to advance our understanding of GI disease and aid in the development of new microbiome-based therapeutics.
Exposure to IBD Drugs Could Increase Leukemia Risk
Immunosuppressive drugs called thiopurines have been found to increase the risk of myeloid disorders, such as acute myeloid leukemia and myelodysplastic syndrome, a rare bone marrow disorder, seven-fold among IBD patients.
Statin Use Decreases the Risk of Barrett's Esophagus
AGA Institute Journal Embargo Policy
When a manuscript is accepted for publication in either Gastroenterology or Clinical Gastroenterology and Hepatology, it is under embargo and not for public release until publication. Articles are typically embargoed until 3 p.m. ET the day of online publication.
Authors are permitted to present their research prior to publication before peers at scientific meetings, but should refrain from distributing copies of their paper, including data tables and figures.
AGA News Release Archives
Patient Education Materials
To help you understand and manage your digestive health condition or to prepare for your procedure, the AGA Institute provides patients with educational information, designed to give you some basic facts and to serve as a starting point for discussions with your doctor.
AGA Expert Blog Posts
AGA experts are blogging about new research and hot topics in gastroenterology. View the most recent posts.
AGA Senior Director of Public Relations